nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
|
Tanner, M. |
|
|
16 |
2 |
p. 273-278 |
artikel |
2 |
A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations
|
Lorenzo Bermejo, J. |
|
|
16 |
2 |
p. 322-329 |
artikel |
3 |
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
|
Borner, M.M. |
|
|
16 |
2 |
p. 282-288 |
artikel |
4 |
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications
|
Puglisi, F. |
|
|
16 |
2 |
p. 263-266 |
artikel |
5 |
Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patientswith multiple myeloma
|
Avilés, A. |
|
|
16 |
2 |
p. 219-221 |
artikel |
6 |
Calreticulin expression in neuroblastoma—a novel independent prognostic factor
|
Hsu, W.M. |
|
|
16 |
2 |
p. 314-321 |
artikel |
7 |
Cancer Chemoprevention Vol. 1. Promising Cancer Chemopreventive Agents
|
van Zandwijk, N. |
|
|
16 |
2 |
p. 337 |
artikel |
8 |
Can patients with early-stage diffuse large B-cell lymphoma be treated without bone marrow biopsy?
|
Lim, S.T. |
|
|
16 |
2 |
p. 215-218 |
artikel |
9 |
Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma
|
Katsaros, D. |
|
|
16 |
2 |
p. 300-306 |
artikel |
10 |
Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years
|
Au, W.-Y. |
|
|
16 |
2 |
p. 206-214 |
artikel |
11 |
Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial
|
Pectasides, D. |
|
|
16 |
2 |
p. 294-299 |
artikel |
12 |
Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes
|
Stathopoulos, E.N. |
|
|
16 |
2 |
p. 240-246 |
artikel |
13 |
Development of axillary surgery in breast cancer
|
Luini, A. |
|
|
16 |
2 |
p. 259-262 |
artikel |
14 |
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
|
Spano, J.P. |
|
|
16 |
2 |
p. 189-194 |
artikel |
15 |
Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)–paclitaxel or docetaxel adjuvant chemotherapy in breast cancer
|
Schwartz, J. |
|
|
16 |
2 |
p. 247-252 |
artikel |
16 |
Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival
|
Cleator, S.J. |
|
|
16 |
2 |
p. 267-272 |
artikel |
17 |
Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia
|
van Tiel, F.H. |
|
|
16 |
2 |
p. 195-205 |
artikel |
18 |
Intra-arterial hepatic chemotherapy in heavily pretreated patients with epithelial ovarian cancer
|
Mambrini, A. |
|
|
16 |
2 |
p. 334-335 |
artikel |
19 |
Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology
|
Pentheroudakis, G. |
|
|
16 |
2 |
p. 181-188 |
artikel |
20 |
Long-term survival after surgical intervention for bone disease in multiple myeloma
|
Zeifang, F. |
|
|
16 |
2 |
p. 222-227 |
artikel |
21 |
Multiple Myeloma and Related Disorders
|
Bertolini, F. |
|
|
16 |
2 |
p. 337 |
artikel |
22 |
Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients
|
Altundag, K. |
|
|
16 |
2 |
p. 333 |
artikel |
23 |
Outpatient management in patients with neutropenia after intensive chemotherapy—is it safe?
|
Kern, W.V. |
|
|
16 |
2 |
p. 179-180 |
artikel |
24 |
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
|
Thongprasert, S. |
|
|
16 |
2 |
p. 279-281 |
artikel |
25 |
Phase II study of troxacitabine in chemotherapy-naïve patients with advanced cancer of the pancreas
|
Lapointe, R. |
|
|
16 |
2 |
p. 289-293 |
artikel |
26 |
Reply to the Letter to the Editor on “Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients”, by K. Altundag et al. (Ann Oncol 2005; 16: 333)
|
Berclaz, G. |
|
|
16 |
2 |
p. 333-334 |
artikel |
27 |
Reply to the Letter to the Editor on ‘Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity?’, by M. Sebagh, M. Plasse, F. Lévi & R. Adam (Ann Oncol 2005; 16: 331)
|
Rubbia-Brandt, L. |
|
|
16 |
2 |
p. 332-333 |
artikel |
28 |
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials
|
Pagano, L. |
|
|
16 |
2 |
p. 228-233 |
artikel |
29 |
Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate
|
Fornier, M.N. |
|
|
16 |
2 |
p. 234-239 |
artikel |
30 |
Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity?
|
Sebagh, M. |
|
|
16 |
2 |
p. 331 |
artikel |
31 |
Table of Contents
|
|
|
|
16 |
2 |
p. i-ii |
artikel |
32 |
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
|
Bamias, A. |
|
|
16 |
2 |
p. 307-313 |
artikel |
33 |
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
|
Del Mastro, L. |
|
|
16 |
2 |
p. 253-258 |
artikel |